Innovus Pharmaceuticals, Inc. (INNV) Initiates Safety and Efficacy Study of Vesele® in Combination with Viagra®

Company: Innovus Pharmaceuticals, Inc. (INNV)
Category: News

Innovus Pharmaceuticals (OTCQB: INNV), a commercial-stage pharmaceutical company focused on over-the-counter medicines and consumer care products for men’s and women’s health and respiratory diseases, has initiated a pre-clinical and clinical program to evaluate the safety and efficacy of its supplement Vesele® for promoting sexual health in combination with sildenafil indicated for treating erectile dysfunction. In the U.S., sildenafil is sold under the name Viagra® by Pfizer, Inc. (NYSE: PFE). In a previously announced human clinical survey to evaluate erectile dysfunction and sexual satisfaction in men using Vesele®, the drug showed favorable results.

To view the full press release, visit: http://nnw.fm/nCgK6

About Innovus Pharmaceuticals, Inc.

Headquartered in San Diego, Innovus Pharma is an emerging commercial stage pharmaceutical company delivering over-the-counter medicines and consumer care products for men’s and women’s health and respiratory diseases. The Company generates revenues from its lead products (a) BTH® Testosterone Booster, (b) BTH® Human Growth Agent, (c) Zestra® for female arousal and (d) EjectDelay® for premature ejaculation and has an additional five marketed products in this space, including (e) Sensum+® to help with reduced penile sensitivity, (f) Zestra Glide®, (g)Vesele® for promoting sexual health, (h) RecalMax™ for promoting brain and cognitive health, (i) Androferti® (in the US and Canada) to support overall male reproductive health and sperm quality, (j) BTH Vision Formula, (k) BTH Blood Sugar, among others and eventually FlutiCare™ OTC for allergic rhinitis, if its ANDA is approved by the U.S. FDA. For more information, go to www.innovuspharma.com

About NetworkNewsBreak

NetworkNewsBreak is a rapid summary of a press release that caught the attention of NetworkNewsWire (NNW). NNW provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing network of more than 5,000 key distribution outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, visit https://www.networknewswire.com.

Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.net

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217